Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
https://www.axios.com/2025/12/07/bessent-soybeans-farmers-china...
https://www.newsnationnow.com/politics/sen-cotton-identities-of-those-on-alleged-drug-boat-are-known/...
